{"version":"1.0","provider_name":"Transcrime","provider_url":"https:\/\/www.transcrime.it\/en\/","author_name":"Transcrime","author_url":"https:\/\/www.transcrime.it\/en\/author\/carlo\/","title":"Promenade: Operational Trials and External End-User Webinar - Transcrime","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"eeDe4AW3jT\"><a href=\"https:\/\/www.transcrime.it\/en\/promenade-operational-trials-and-external-end-user-webinar\/\">Promenade: Operational Trials and External End-User Webinar<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.transcrime.it\/en\/promenade-operational-trials-and-external-end-user-webinar\/embed\/#?secret=eeDe4AW3jT\" width=\"600\" height=\"338\" title=\"&#8220;Promenade: Operational Trials and External End-User Webinar&#8221; &#8212; Transcrime\" data-secret=\"eeDe4AW3jT\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.transcrime.it\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.transcrime.it\/wp-content\/uploads\/2023\/04\/Promenade_ServicesPortfolio_PPT_cover-2.jpg","thumbnail_width":1800,"thumbnail_height":1013,"description":"In March, the operational trials phase of the Toolkit developed in PROMENADE was successfully concluded, in collaboration with four EU Border Guards (in Greece, Spain, Lithuania and France).\u00a0 Within the project, Transcrime has developed Risk Investigator, an innovative tool to:\u00a0 trace ownership structures and Beneficial Owners of vessels, even when deploying across borders;\u202f\u00a0 identify adverse [&hellip;]"}